Restriction enzyme MaeIII for prenatal diagnosis of alpha 1-antitrypsin deficiency

What a paediatric pulmonologist needs to know about vaping.

Paediatric respiratory reviews·2025

The role of rhinovirus infections in young children with cystic fibrosis.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2020

The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis

Irish medical journal·2019

Pulmonary aspiration in preschool children with cystic fibrosis.

Respiratory research·2018

Diagnosis and treatment of sleep related breathing disorders in children: 2007 to 2011.

Irish medical journal·2015

Rhinovirus and the developing lung.

Paediatric respiratory reviews·2014

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Neurogenetics·2026

Evaluation of genetic parameters affecting the reliability and effectiveness of kinship reconstruction in Forest and Tundra Nenets populations using X-STR markers.

Vavilovskii zhurnal genetiki i selektsii·2026

Case Report: A novel 1, 171 bp GCK promoter/exon 1 deletion in a Chinese pedigree: correcting a misdiagnosis of MODY10 based on an incidental INS variant.

Frontiers in endocrinology·2026

A novel variant c.1185_1196dup (p.(Gly396_Ser399dup)) in the SLC26A4 gene associated with recessive hearing loss.

Vavilovskii zhurnal genetiki i selektsii·2026

Optical genome mapping identifies clinically relevant somatic structural variation in epilepsy-affected brain tissue.

Genome research·2026

Genetic Susceptibility in Relative Maternal Protection From Type 1 Diabetes.

Diabetes care·2026

Related Experiment Videos

Restriction enzyme MaeIII for prenatal diagnosis of alpha 1-antitrypsin deficiency

Related Concept Videos

What a paediatric pulmonologist needs to know about vaping.

The role of rhinovirus infections in young children with cystic fibrosis.

The Prevalence of Pseudomonas Aeruginosa Infection Over a Ten-Year Period in Children with Cystic Fibrosis

Pulmonary aspiration in preschool children with cystic fibrosis.

Diagnosis and treatment of sleep related breathing disorders in children: 2007 to 2011.

Rhinovirus and the developing lung.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Founder mutations in movement disorders: global distribution, molecular mechanisms, and clinical consequences-a scoping review.

Evaluation of genetic parameters affecting the reliability and effectiveness of kinship reconstruction in Forest and Tundra Nenets populations using X-STR markers.

Case Report: A novel 1, 171 bp GCK promoter/exon 1 deletion in a Chinese pedigree: correcting a misdiagnosis of MODY10 based on an incidental INS variant.

A novel variant c.1185_1196dup (p.(Gly396_Ser399dup)) in the SLC26A4 gene associated with recessive hearing loss.

Optical genome mapping identifies clinically relevant somatic structural variation in epilepsy-affected brain tissue.

Genetic Susceptibility in Relative Maternal Protection From Type 1 Diabetes.

Related Experiment Videos

Restriction enzyme MaeIII for prenatal diagnosis of alpha 1-antitrypsin deficiency

Related Concept Videos

Related Articles